| R-0201 | C52H72N12O10 | 1025.22 | 50410-01-0 | H-His-Pro-Phe-His-Leu-D-Leu-Val-Tyr-OH | |
| R-0202 | PHPFHLFVY | C60H77N13O11 | 1156.35 | H-Pro-His-Pro-Phe-His-Leu-Phe-Val-Tyr-OH | |
| R-0203 | PHPFHFFVYK | C69H87N15O12 | 1318.54 | 75645-19-1 | H-Pro-His-Pro-Phe-His-Phe-Phe-Val-Tyr-Lys-OH |
| R-0204 | C72H110N20O15 | 1495.79 | 93287-54-8 | Z-Arg-Arg-Pro-Phe-His-Sta-Ile-His-Lys(Boc)-Ome | |
| R-0205 | C30H38N4O6 | 550.66 | 76524-85-1 | H-Leu-Val-Tyr-AMC | |
| R-0206 | Preangiotensinogen (11-14) (human) | C21H35N7O6 | 481.55 | 102813-98-9 | H-Val-Ile-His-Asn-OH |
| R-0301 | Acetyl-Tetradecapeptide Renin Substrate (horse), Acetyl-Angiotensinogen (1-14) (horse), Acetyl-Preangiotensinogen (1-14) (horse) | C87H125N21O21 | 1801.08 | 66641-26-7 | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH |
| R-0302 | Acetyl-Tetradecapeptide Renin Substrate (human), Acetyl-Angiotensinogen (1-14) (human), Acetyl-Preangiotensinogen (1-14) (human) | C85H124N24O20 | 1802.07 | 104180-27-0 | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn-OH |
| R-0303 | Tetradecapeptide Renin Substrate (rat), Angiotensinogen (1-14) (rat), Preangiotensinogen (1-14) (rat) | C89H123N21O21 | 1823.08 | 110200-37-8 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr-Tyr-Ser-OH |
| R-0304 | Tetradecapeptide Renin Substrate (horse), Angiotensinogen (1-14) (horse), Preangiotensinogen (1-14) (horse) | C85H123N21O20 | 1759.04 | 20845-02-7 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH |
